Irradiation of platelet components: Inhibition of lymphocyte proliferation assessed by limiting-dilution analysis

Transfusion

Volumn 40, Issue 3, 2000, Pages 348-352

  Luban, Naomi L C ^a   Drothler, D ^b   Moroff, G ^b   Quinones, R ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL COUNT; CELL GROWTH; CELL ISOLATION; CELL VIABILITY; GAMMA IRRADIATION; HUMAN; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NORMAL HUMAN; T LYMPHOCYTE; THROMBOCYTOPHERESIS;

ADULT; ANTIGENS, CD56; BLOOD PLATELETS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMANS; INDICATOR DILUTION TECHNIQUES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PLATELETPHERESIS; T-LYMPHOCYTES;

EID: 0034104684     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030348.x     Document Type: Article

References (25)

1. Brubaker DB. Immunopathogenic mechanisms of posttransfusion graft vs host disease. Proc Soc Exp Biol Med 1993;202:122-47.
2. Kanter MH. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first degree relatives? Transfusion 1992;32:323-7.
3. Kernan KA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986;68:770-3.
4. Drobyski W, Thibodeau S, Truitt RL, et al. Third-party mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 1989;74:2285-94.
5. Lowenthal RM, Challis DR, Griffiths AE, et al. Transfusion-associated graft-versus-host disease: report of an occurrence following administration of irradiated blood. Transfusion 1993;33:524-9.
6. Sproul AM, Chalmers EA, Mills KI, et al. Third party mediated graft rejection despite irradiation of blood products. Br J Haematol 1992;80:251-2.
7. Moroff G, Luban NLC, Wolf L, Yoder RC. Dosimetry measurements after gamma irradiation with cesium-137 and linear acceleration sources (abstract). Transfusion 1993;33(Suppl):52S.
8. Pelszynski MM, Moroff G, Luban NL, et al. Effect of γ irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994;83:1683-9.
9. Lucas PJ, Quinones RR, Moses RD, et al. Alternative donor sources in HLA-mismatched marrow transplantation: T cell depletion of surgically resected cadaveric marrow. Bone Marrow Transplant 1988;3:211-20.
10. Quinones RR, Gutierrez RH, Dinndorf PA, et al. Extended cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation. Blood 1993;82:307-17.
11. Moretta A, Pantaleo G, Moretta L, et al. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 1985;157:743-54.
12. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981;126:1614-9.
13. Sprent J, Anderson RE, Miller JF. Radiosensitivity of T and B lymphocytes. II. Effect of radiation of response on T cells to alloantigens. Eur J Immunol 1974;4:204-10.
14. Button LN, DeWolf WC, Newberger PE, et al. The effects of irradiation on blood components. Transfusion 1981;21:419-26.
15. Valerius NH, Johansen KS, Nielsen OS, et al. Effect of in vitro x-irradiation on lymphocyte and granulocyte function. Scand J Hematol 1981;27:9-18.
16. Moroff G, Luban NL. The irradiation of blood and blood components to prevent graft-versus-host disease: technical issues and guidelines. Transfus Med Rev 1997;11:15-26.
17. Rosen NR, Weidner JG, Boldt HD, Rosen DS. Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma irradiation. Transfusion 1993;33:125-7.
18. Korngold R. Biology of graft-versus-host disease. Am J Pediatr Hematol Oncol 1993;15:18-37.
19. Ferrara JL, Krenger W. Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines. Transfus Med Rev 1998;12:1-17.
20. Sweeney JD, Holmes S, Moroff G. Storage of apheresis platelets after gamma radiation. Transfusion 1994;34:779-83.
21. Seghatchian MJ, Stivala JF. Effect of 25 Gy gamma irradiation on storage stability of three types of platelet concentrates: a comparative analysis with paired controls and random preparations. Transfus Sci 1995;16:125-9.
22. Read EJ, Kodis C, Carter CS, Leitman SE. Viability of platelets following storage in the irradiated state. A pair-controlled study. Transfusion 1988;28:446-50.
23. Akahoshi M, Takanashi M, Masuda M, et al. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992;32:169-72.
24. Heim MU, Munker R, Sauer H, et al. [Graft-versus-host disease with fatal outcome after administration of filtered erythrocyte concentrates] (Engl abstract). Beitr Infusionsther 1992;30:178-81.
25. Hayashi H, Nishiuchi T, Taurma H, et al. Transfusion associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 1993;79:1419-21.